Healthcare Reform ONC-AHIMA Public-Private Guide on Privacy and Security of Electronic Health… Thomas Sullivan Jun 5, 2012 0 The Office of the National Coordinator for Health IT recently release a new instructional guide addressing concerns about privacy…
Open Payments Physician Payment Sunshine: Former Prosecutors Asks What Happened to… Thomas Sullivan Jun 5, 2012 0 Many sections of the recently enacted Patient Protection and Affordable Care Act (PPACA) are delegated to the Executive Branch,…
Open Payments Physician Payment Sunshine: Study Shows No Difference in Prescribing… Thomas Sullivan Jun 4, 2012 0 The Physician Payment Sunshine Act requires pharmaceutical and medical device manufacturers to report certain payments made to…
Events CBI 10th Annual Forum on Educational Grants Thomas Sullivan Jun 1, 2012 0 As pharmaceutical companies continue to change their granting policies and procedures to stay focused on quality improvement…
Clinical Research Pharmaceutical Companies Adopt 10 Recommendations for Clinical Trial… Thomas Sullivan May 31, 2012 0 A recent article from amednews noted how “Eight leading pharmaceutical companies have approved 10 recommendations aimed at…
Conflict of Interest Study Shows Restricting Sales Reps Access May Be Dangerous to Your Health Thomas Sullivan May 31, 2012 0 Over the last decade or so, we have seen a tremendous amount of attention surrounding the use and influence of pharmaceutical…
CME AAMC: CME Aligning and Educating for Quality Thomas Sullivan May 30, 2012 0 In a recent article published by the American Association of Medical Colleges (AAMC), two authors challenged traditional…
CME The ABC’s of Accredited CME Thomas Sullivan May 30, 2012 0 Accredited CME plays an important role not only in assisting physicians in maintenance of licensure but with maintenance of…
Congress Physician Payment Sunshine Act: Phazysician Congressman Ask CMS for Changes… Thomas Sullivan May 29, 2012 0 Since the Centers for Medicare and Medicaid Services (CMS) announced that it would be delaying the collection of payment…
International Foreign Corrupt Practices Act: Life Science Companies and Emerging Markets Thomas Sullivan May 25, 2012 0 Last year, Johnson & Johnson announced that it will pay $70 million as part of a deferred prosecution agreement (DPA) with the…